News
FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
The FDA plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...
The agency plans to release more information about the AI adoption initiative in June, according to the release. The AI rollout is being led by Jeremy Walsh, the FDA’s freshly tapped chief AI ...
WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...
AI’s Expanded Role in the Life Sciences Regulatory Review Process: Key Developments in U.S. and EU
Overview - - The U.S. Food and Drug Administration (FDA) announced that it aims to increase the agency’s use of artificial intelligence (AI) ...
The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...
The FDA is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, part of a bid to get faster and leaner in evaluating drugs, foods, medical devices and diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results